This series investigates the growing interest from the pharmaceutical industry in cannabinoids. In this first piece, we hear from industry experts about the current situation of the ingredient on the pharmaceutical market.

Learn how Raman microscopy can help solve some of the biggest challenges in 3D imaging and microparticle analysis.

An MHRA consultation is due to end on 31 August, with public comments on AQbD principles closing soon.

The cancer therapeutic, Rozlytrek, has gained FDA approval as well as Priority Review, Breakthrough Therapy and Orphan Drug Designations.

Researchers have developed silica spheres to contain cancer therapeutics that melt at certain temperatures and have the potential to improve drug delivery.